Related Experiment Video
Updated: Jul 14, 2026
Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
A pathologist's perspective on emerging genomic tests for breast cancer.
1Department of Pathology, The University of Texas, M. D. Anderson Cancer Center, Houston, TX 77030, USA. fsymmans@mdanderson.org
New molecular tests for breast cancer promise to advance diagnostic pathology and patient care. The key challenge is standardizing these research findings into reliable clinical tests for routine use.
Area of Science:
- Oncology
- Molecular Diagnostics
- Pathology
Background:
- Advancements in molecular testing are transforming breast cancer diagnostics.
- Translating research discoveries into clinical practice remains a significant hurdle.
Purpose of the Study:
- To highlight the potential of emerging molecular tests in breast cancer diagnostics.
- To address the challenges in integrating these tests into routine clinical work-up.
Main Methods:
- Review of current research in molecular pathology for breast cancer.
- Analysis of the requirements for clinical standardization of diagnostic tests.
Main Results:
- Molecular tests show promise for guiding breast cancer patient care.
- Standardization and reliability are critical for clinical adoption.
Conclusions:
- Emerging molecular tests represent a significant future direction for breast cancer diagnostics.
- Successful clinical integration requires robust standardization to ensure accuracy and reliability.
More Related Videos
08:15gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
Published on: October 6, 2014
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020